11 results

• Nearly 200 Women Pursuing BioZorb Lawsuits Over Complications With Breast Tissue Marker

  August 11, 2025

  Irvin Jackson

  Hologic faces at least 183 BioZorb lawsuits, a number which continues to grow as the first bellwether trial is pushed back to January 2026.

• Problems With Recalled BioZorb Markers Could Cause Severe Injury or Death, FDA Warns

  December 19, 2024

  Irvin Jackson

  The FDA is giving a recent BioZorb marker recall a class I designation, indicating the federal agency believes problems with the device, implanted to assist in targeted therapy in breast cancer patients, can cause serious injuries and potentially death.

• BioZorb Marker Lawsuits Involving 100 Different Plaintiffs Pending in District of Massachusetts

  December 12, 2024

  Irvin Jackson

  Lawsuits allege that recalled BioZorb Markers failed to absorb into the body after breast cancer treatments, resulting in painful complications and the need for additional medical procedures.

• BioZorb Recall Issued for All Breast Tissue Markers Following Implant Migration, Erosion Problems

  October 25, 2024

  Irvin Jackson

  The FDA is calling for doctors to stop using BioZorb Marker implants, due to serious complications in breast cancer patients, which has led Hologic to remove all remaining devices from the market.

• Lawsuit Alleges Depo-Provera Caused Intracranial Meningioma Brain Tumors

  October 23, 2024

  Irvin Jackson

  California woman claims Pfizer knew about the risks of intracranial meningioma brain tumors from Depo-Provera birth control shots since the 1980s, but failed to provide adequate warnings to U.S. doctors and consumers.

• Depo-Provera Shot Lawsuit Filed Over Brain Tumor That Required Surgical Removal and Radiation Treatments

  October 16, 2024

  Irvin Jackson

  Indiana woman alleges that Pfizer failed to warn about the risk that side effects of the Depo-Provera shot may cause meningioma brain tumors.

• BioZorb Implant Complications Result in Lawsuit Brought by 7 Breast Cancer Survivors

  July 26, 2024

  Irvin Jackson

  A Biozorb tissue marker lawsuit filed by seven women claim the implant is defectively designed, and prone to cause a variety of complications, such as pain, lumps, device migration and infections.

• BioZorb Marker Recall Issued After Dozens of Injuries Linked to the Radiographic Implants

  May 23, 2024

  Grace Muller

  Nearly 54,000 BioZorb Markers, used in breast cancer treatment, are being recalled following dozens of reports of injuries, including implant migration.

• Radiation Therapy Unnecessary for Some Rectal Cancer Patients: Study

  June 9, 2023

  Stephanie Yanovich

  A new study finds chemotherapy is often just as effective at treating early rectal cancer as radiation therapy, but without many of the harmful side effects.

• Low Levels of Radiation Exposure Could Increase Risk of Heart Disease, Researchers Warn

  March 17, 2023

  Martha Garcia

  The findings of a new study link an increased risk of cardiovascular disease to much lower doses of radiation exposure than previously believed.